In the present study, hydrophilic surface coating of drug-loaded CA particles by PEG and a cell specific ligand, fibronectin was designed to increase targeting specificity and delivery efficiency of the particle drug complex into breast cancer cells (Figure 12). This evidence concerns the gene FN1 and breast cancer.